carbon tetrachloride has been researched along with tak 044 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gandhi, CR; Nemoto, EM; Subbotin, VM; Watkins, SC | 1 |
Anselmi, K; Gandhi, CR; Nemoto, E; Subbotin, VM | 1 |
Fung, J; Gandhi, CR; Harvey, SA; Subbotin, VM; Thirunavukkarasu, C; Yang, Y | 1 |
3 other study(ies) available for carbon tetrachloride and tak 044
Article | Year |
---|---|
An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin | 1998 |
Accelerated reversal of carbon tetrachloride-induced cirrhosis in rats by the endothelin receptor antagonist TAK-044.
Topics: Animals; Arteries; Blood Pressure; Carbon Tetrachloride; Collagen; Collagenases; Endothelin Receptor Antagonists; Endothelin-1; Hydroxyproline; Liver; Liver Cirrhosis; Male; Peptides, Cyclic; Portal Vein; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Topics: Animals; Carbon Tetrachloride; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin | 2004 |